Literature DB >> 16734782

The substrate specificity of cruzipain 2, a cysteine protease isoform from Trypanosoma cruzi.

Flavia C G dos Reis1, Wagner A S Júdice, Maria A Juliano, Luiz Juliano, Julio Scharfstein, Ana Paula C de A Lima.   

Abstract

Papain-like cysteine proteases are important for the survival of the flagellated protozoa Trypanosoma cruzi, the causative agent of Chagas' Disease. The lysosomal cysteine protease designated as cruzipain or cruzain, is the archetype of a multigene family of related isoforms. We investigated the substrate specificity of the cruzipain 2 isoform using internally quenched fluorogenic substrates. We found that cruzipain 2 and cruzain differ substantially regarding the specificity in the S2, S'1 and S'2 pockets. Our study indicates that cruzipain 2 has a more restricted specificity than cruzain, suggesting that these isoforms might act on distinct natural substrates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734782     DOI: 10.1111/j.1574-6968.2006.00267.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

Review 1.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

2.  In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.

Authors:  Yen Ting Chen; Linda S Brinen; Iain D Kerr; Elizabeth Hansell; Patricia S Doyle; James H McKerrow; William R Roush
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

3.  Major cysteine protease (cruzipain) in Z3 sylvatic isolates of Trypanosoma cruzi from Rio de Janeiro, Brazil.

Authors:  S A O Gomes; D Misael; B A Silva; D Feder; C S Silva; T C M Gonçalves; A L S Santos; J R Santos-Mallet
Journal:  Parasitol Res       Date:  2009-05-13       Impact factor: 2.289

4.  Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut.

Authors:  Lívia Almeida Uehara; Otacílio C Moreira; Ana Carolina Oliveira; Patrícia Azambuja; Ana Paula Cabral Araujo Lima; Constança Britto; André Luis Souza dos Santos; Marta Helena Branquinha; Claudia Masini d'Avila-Levy
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

5.  Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion.

Authors:  Patrícia Mello Ferrão; Claudia Masini d'Avila-Levy; Tania Cremonini Araujo-Jorge; Wim Maurits Degrave; Antônio da Silva Gonçalves; Luciana Ribeiro Garzoni; Ana Paula Lima; Jean Jacques Feige; Sabine Bailly; Leila Mendonça-Lima; Mariana Caldas Waghabi
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 6.  A Brief View of the Surface Membrane Proteins from Trypanosoma cruzi.

Authors:  Ángel de la Cruz Pech-Canul; Victor Monteón; Rosa-Lidia Solís-Oviedo
Journal:  J Parasitol Res       Date:  2017-06-05

7.  Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors.

Authors:  Antonio C B Burtoloso; Sérgio de Albuquerque; Mark Furber; Juliana C Gomes; Cristiana Gonçalez; Peter W Kenny; Andrei Leitão; Carlos A Montanari; José Carlos Quilles; Jean F R Ribeiro; Josmar R Rocha
Journal:  PLoS Negl Trop Dis       Date:  2017-02-21

8.  Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi.

Authors:  Natacha Cerny; Augusto Ernesto Bivona; Andrés Sanchez Alberti; Sebastián Nicolás Trinitario; Celina Morales; Alejandro Cardoso Landaburu; Silvia Inés Cazorla; Emilio Luis Malchiodi
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

9.  The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites.

Authors:  Viviane Corrêa Santos; Antonio Edson Rocha Oliveira; Augusto César Broilo Campos; João Luís Reis-Cunha; Daniella Castanheira Bartholomeu; Santuza Maria Ribeiro Teixeira; Ana Paula C A Lima; Rafaela Salgado Ferreira
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.